Apogee Therapeutics (NASDAQ:APGE – Get Free Report) announced its quarterly earnings results on Monday. The company reported ($3.78) EPS for the quarter, missing analysts’ consensus estimates of ($2.49) by ($1.29), MarketWatch Earnings reports. Apogee Therapeutics Price Performance APGE opened at $23.50 on Wednesday. Apogee Therapeutics has a 1-year low of $19.98 and a 1-year high […]